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Saccharomyces cerevisiae Bpt1p is an ATP-binding cassette (ABC) protein that belongs to the MRP subfamily
and is a close homologue of the glutathione conjugate (GS conjugate) transporter Ycf1p. The function of Bpt1p
has previously been evaluated only in vitro, by using nonphysiological substrates. In the present study we
examined the localization, regulation, and transport properties of Bpt1p in vivo, as well as its capacity to
transport a set of prototypical MRP substrates in vitro. Our results show that Bpt1p, like Ycf1p, localizes to
the yeast vacuolar membrane, plays a role in cadmium detoxification and ade2 pigmentation in vivo, and can
participate in the transport of GS conjugates and glucuronate conjugates, as well as free glutathione, in vitro.
However, in all of these cases the contribution of Bpt1p is substantially less than that of Ycf1p. In addition, the
expression patterns of YCF1 and BPT1 differ significantly. Whereas YCF1 expression is markedly increased by
cadmium, adenine limitation in an ade2 strain, or overexpression of the stress-responsive transcription factor
Yap1p, BPT1 expression is only modestly affected under these conditions. Thus, although the functional
capabilities of Bpt1p and Ycf1p overlap, their differences in regulation and substrate preference imply that they
contribute to cellular detoxification processes in different ways.
With the complete genome of numerous organisms now in
hand, the ATP-binding cassette (ABC) transporter superfam-
ily has emerged as the largest membrane protein superfamily
in both prokaryotes and eukaryotes, including microbes,
plants, and animals (10–12, 17, 40, 45). Members of this su-
perfamily catalyze the MgATP-energized transport of a broad
range of substrates across biological membranes. Mutational
loss of function of ABC proteins has been implicated in an
increasing number of inherited diseases (11), and overexpres-
sion of certain ABC transporters has been shown to enhance
multidrug resistance and the elimination of xenobiotics (1, 2).
Consequently, elucidation of the biochemical activity, sub-
strate specificity, and physiological regulation of ABC trans-
porters is of both clinical and general biological significance.
Phylogenetic analysis has provided a valuable road map for
formulating hypotheses about the function and substrate(s) of
a particular transporter. ABC proteins can be divided into
seven subfamilies based on sequence relatedness, designated
ABCA through ABCG (11, 12, 45; http://nutrigene.4t.com/
humanabc.htm). The emergent view is that members of a par-
ticular subfamily are likely to exhibit some degree of overlap in
substrate specificity and/or function. This point is well illus-
trated by members of the human ABCC subfamily, also des-
ignated the multidrug resistance-associated protein (MRP)
subfamily, several of which participate in cellular detoxification
processes.
In humans, the ABCC/MRP subfamily contains 12 mem-
bers, 5 of which (MRP1 through MRP5) are implicated in
multidrug transport. Critically, most drugs are either trans-
ported by the MRPs in the form of conjugates of glutathione
(GS), glucuronide, or sulfate or, alternatively, are not conju-
gated but instead undergo cotransport with free glutathione
(GSH) (2). In addition to exogenously added drugs, molecules
that are endogenously produced in cells during normal physi-
ological processes can also be MRP substrates. For instance,
inherited defects in the MRP2 gene result in Dubin-Johnson
syndrome, a disorder characterized by reduced excretion of
bilirubin-glucuronides from liver cells (35, 36, 48). The general
consensus is that MRPs mediate cellular detoxification pro-
cesses by excreting potentially harmful endogenously and ex-
ogenously derived compounds, after these compounds have
been rendered anionic by conjugation to GSH or glucuronate,
or through complexing with GSH.
To gain further insight into multidrug resistance, it is impor-
tant to understand how an organism may benefit by having
multiple, highly homologous MRPs. Comparisons of the prop-
erties of the human MRP1, MRP2, and MRP3 transporters
suggest several possibilities (3, 18, 21). First, these three MRPs
appear to have overlapping, but distinct, substrate and kinetic
profiles. Second, their intracellular sites of localization differ.
Third, their regulatory properties differ, resulting in distinct
patterns of tissue expression and/or response to extracellular
stress (i.e., oxidative stress) (7). The combined effect of differ-
ences in these three parameters (spectrum of substrate speci-
ficity, location, and regulation) could impart a sufficiently high
degree of specificity and flexibility to explain the distinctive
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physiological roles of particular MRPs and to account for their
large numbers in all organisms.
The yeast Saccharomyces cerevisiae presents a highly manip-
ulable system for the genetic and biochemical analysis of both
endogenous and heterologous ABC proteins (12, 45). Yeast
encodes six MRP subfamily members, of which the vacuolar
GS conjugate pump Ycf1p is the most thoroughly character-
ized (23, 25). Ycf1p can transport organic GS conjugates and
Cd · glutathione (Cd · GS) complexes into the vacuole (23, 25,
44). Deletion of YCF1 results in hypersensitivity to cadmium,
while overexpression confers cadmium resistance. Ycf1p
shares many biochemical properties with mammalian MRP1,
and significantly, human MRP1 restores GS conjugate trans-
port and cadmium resistance in ycf1-defective yeast strains
(46). In addition, Ycf1p has been found to confer resistance to
arsenite and diamide, and it is required for the vacuolar accu-
mulation of a pigment precursor in ade2 mutants (5, 14, 49).
The closest homologue of YCF1 in yeast is YLL015. Since
YLL015 was discovered through the yeast genome sequence
project and not from mutant or overexpression screens, its in
vivo function as a transporter has been only hypothetical. Re-
cently, a biochemical study indicated that YLL015, like YCF1,
can mediate the in vitro transport of unconjugated bilirubin
into yeast vacuole-derived vesicles (37). Accordingly, the gene
has been designated BPT1 (named BPT for bile pigment trans-
porter), even though this particular substrate is unlikely to
have direct physiological relevance for yeast. Bpt1p and Ycf1p
have also been shown to have overlapping activity for the in
vitro transport of other nonphysiological substrates, including
several Gd-based magnetic resonance imaging (MRI) contrast
agents (34).
In the present study we have compared the localization,
regulation, and transport properties of Bpt1p and Ycflp both in
vivo and in vitro. Our results show that Bpt1p, like Ycf1p,
localizes to the vacuolar membrane, participates in cadmium
detoxification and ade2 pigmentation in vivo, and has the ca-
pacity to catalyze the transport of GS and glucuronate conju-
gates, as well as that of free GSH in vitro. Although the trans-
port properties of Bpt1p and Ycf1p overlap, their cellular
impacts seem to differ considerably: the overall phenotypic and
biochemical contributions of YCF1 consistently exceed those
of BPT1. These differences in contribution may be due in part
to differences in substrate selectivity and in part to the relative
levels of each transporter, as determined by differences in their
patterns of regulation. An interesting feature observed for
some of the substrates was an unexpected dependence of
Bpt1p on Ycf1p for maximal transport activity in vitro. Of the
several potential explanations for this phenomenon, one in-
triguing possibility is that Bpt1p and Ycf1p form functional
heterodimers.
MATERIALS AND METHODS
Yeast strains. The strains used in this study are listed in Table 1. A chromosomal
disruption of BPT1 was generated in the ade2 haploid strains YPH499 (here desig-
nated ABC154) and YPH500 (42) by using PCR-mediated gene disruption with the
KanMX2 module (47) to replace codons 428 to 736 of Bpt1p, yielding ABC791 and
ABC790, respectively. A double mutant, ABC794 (ycf1::KanMX2
bpt1::KanMX2), was constructed by dissecting tetrads derived from a diploid gen-
erated by a cross between ABC470 and ABC790. Double-disruption segregants were
found to be viable. The presence of both disruptions was confirmed by PCR.
Single and double disruptions of YCF1 and BPT1 in the ADE2 diploid strain
SM1060 (30) were also generated. Chromosomal YCF1 was disrupted from
codon 1 to 1439 by the standard two-step integration-excision method using
plasmid pJAW53, as previously described (50). The diploid was sporulated and
the tetrads were dissected to obtain both MATa (SM3851) and MAT (SM3852)
ycf1 disruptants. A precise open reading frame (ORF) deletion allele of BPT1
was generated in SM1060 by PCR-mediated gene disruption with the KanMX4
module (4, 47). The diploid was sporulated and the tetrads were dissected to
obtain both MATa (SM3794) and MAT (SM3795) bpt1 disruptants. The double
mutant SM3858 (bpt1::KanMX4 ycf1) was constructed by dissecting tetrads
derived from a diploid generated by a cross between SM3852 and SM3794. The
disruptions were confirmed by Southern blot analysis.
A strain containing chromosomal BPT1-GFP was generated by transforming
SwaI-digested pSM1849 into strain SM3794 (bpt1) and selecting for Ura
transformants. One of the transformants, SM4787, which contains BPT1-GFP
integrated adjacent to the KanMX4-disrupted copy of BPT1, was confirmed for
Bpt1p-green fluorescent protein (GFP) expression by Western blot analysis. A
strain containing chromosomal YCF1-GFP was generated by the standard two
step integration-excision method by transforming AvrII-digested pSM1817 into
strain SM3851 (ycf1) and selecting for Ura transformants. The resulting
strain, SM4643, contains YCF1-GFP at the YCF1 locus. Correct integration of
YCF1-GFP was confirmed by Southern blot analysis, and the presence of Ycf1p-
GFP was confirmed by Western blot analysis.
Plasmids and their construction. Plasmids used in this study are listed in Table
2. Plasmid pSM1487 (CEN URA3 BPT1) contains the complete BPT1 ORF
flanked by its native 5 upstream and 3 downstream regions (515 and 500 bp,
respectively) and was constructed in two steps. First, the 5 upstream and 3
downstream regions of BPT1 were amplified from the genome by PCR and
subcloned by three-way ligation into pRS316 (CEN URA3) (42). Next, the BPT1
ORF was cloned into this vector by levitating it from the genome (32). The BPT1
coding sequence in the resulting plasmid, pSM1487 (CEN URA3 BPT1), was
confirmed by DNA sequence analysis. The multicopy plasmid pSM1488 (2m
URA3 BPT1) contains a 5.7-kb KpnI-NotI fragment from pSM1487 subcloned
into the same sites of pSM217 (2m URA3) (6). A GFP-tagged version of BPT1
was constructed by fusing the GFP coding sequence (F64L S65T) immediately
before the stop codon of BPT1 by PCR-mediated recombinational cloning (32)
TABLE 1. Strains used in this study
Strain Relevant genotype Reference or source
ABC154a MATa ura3-52 leu2-1 lys2-801 his3200 trp163 ade2-101 42
ABC470 MATa ycf1::KanMX2 ura3-52 leu2-1 lys2-801 his3200 trp163 ade2-101 5
ABC791 MATa bpt1::KanMX2 ura3-52 leu2-1 lys2-801 his 3200 trp163 ade2-101 This study
ABC794 MAT ycf1::KanMX2 bpt1::KanMX2 ura3-52 leu2-1 lys2-801 his 3200 trp163 ade2-101 This study
SEY6210 MAT leu2-3,112 ura3-52 his3-200 trp1-901 lys2-801 suc2-9 Mel 8
SM13 MAT leu2-3,112 ura3-52 his3-200 trp1-901 lys2-801 suc2-9 Mel yap1-2::hisG 8
SM1058 MATa trp1 leu2 ura3 his4 can1 30
SM3794 MATa bpt1::KanMX4 trp1 leu2 ura3 his4 can1 This study
SM3851 MATa ycf1 trp1 leu2 ura3 his4 can1 This study
SM3858 MATa bpt1::KanMX4 ycf1 trp1 leu2 ura3 his4 can1 This study
SM4643 MATa YCF1-GFP trp1 leu2 ura3 his4 can1 This study
SM4787 MATa bpt1::KanMX4::BPT1-GFP URA3 trp1 leu2 ura3 his4 can1 This study
a This strain is designated YPH499 elsewhere (42).
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to create pSM1489 (CEN URA3 BPT1-GFP). To generate a multicopy version of
this construct, a 6.5-kb KpnI-NotI fragment from pSM1489 was subcloned into
the same sites of pSM217, generating pSM1490 (2m URA3 BPT1-GFP). A
GFP-tagged version of YCF1 was generated by subcloning a 6.0-kb KpnI-SacI
fragment from pJAW50 (50) into KpnI-SacI-digested pSM217. Next, the coding
sequence for GFP (pQBI25; Quantum Biotechnologies, Inc., Montreal, Quebec,
Canada) was fused immediately before the stop codon of YCF1 by PCR-medi-
ated recombinational cloning (32) to yield pSM1753 (2m URA3 YCF1-GFP).
To generate an integrating plasmid expressing BPT1-GFP, we constructed
pSM1849 by subcloning an 8.2-kb PvuI fragment from pSM1490 into the same
sites of pRS306 (42). The YCF1-GFP integrating plasmid pSM1817 contains the
coding sequence from pSM1753 and 1,092 bases of the region downstream of the
YCF1 ORF amplified from pJAW53 (50) subcloned into pRS306 (42).
To construct the BPT1 promoter-reporter fusion plasmid pAB851 (2m URA3
PBPT1 -lacZ), a purified PCR product containing 448 bases upstream of the BPT1
ORF was subcloned into the SmaI site of pBluescript (Stratagene, La Jolla,
Calif.). Next, an XhoI-BamHI fragment was excised and cloned into the BamHI-
XhoI sites of pLG699-Z (2m URA3 lacZ) (16), yielding pAB851. The YCF1
promoter-reporter fusion plasmid pAB852 (2m URA3 PYCF1 -lacZ) was con-
structed by amplifying 418 bases upstream of the YCF1 ORF and subcloning this
purified PCR product into the XhoI-BamHI sites of pLG699-Z. The YCF1
promoter differed from the published sequence at position 302, containing an
insertion of C at this position. The same insertion was observed in clones from
completely independent and separate PCRs and is therefore not an artifact of
PCR. The primers for both plasmids were designed to enable in-frame fusions
with the lacZ gene at the BamHI site in pLG699-Z. The sequences of the
resultant in-frame fusions were confirmed by sequencing.
The sequences of oligonucleotides used for the strain and plasmid construc-
tions will be furnished upon request.
Media and growth conditions. Cells were routinely grown at 30°C in complete
(yeast extract-peptone-dextrose [YPD]) medium or minimal drop-out medium
(i.e., synthetic complete medium without Ura [SC-Ura]) as previously described
(30). YPD medium containing different concentrations of CdCl2 was prepared by
addition of the required amount of CdCl2 immediately prior to the growth
experiment. For pigment quantitation, the liquid YPD medium was limiting for
adenine and contained 0.5% yeast extract rather than 1% yeast extract. The
minimal drop-out plates used for the pigmentation test in Fig. 2 contained a
limited amount of adenine (7.5 mg per liter). The plates used for the cadmium
spot test were prepared by adding the indicated concentration of CdSO4 to the
minimal plate medium.
Fluorescence microscopy. Log-phase cells expressing GFP-tagged Bpt1p and
GFP-tagged Ycf1p were examined at 100 magnification on a polylysine-coated
slide by using a Zeiss Axioskop 2 microscope equipped with fluorescence (HQ
Endow GFP) and Nomarski optics (Zeiss, Thornwood, N.Y.). Images were
captured with a Cooke charge-coupled device camera and IP Lab Spectrum
software (Biovision Technologies, Inc., Exton, Pa.).
-Galactosidase reporter assays. S. cerevisiae SEY6210 (wild type [WT]) or
SM13 (yap1-2) cells were singly transformed with the -galactosidase reporter
plasmids pAB851 (PBPT1 -lacZ) and pAB852 (PYCF1 -lacZ) or doubly trans-
formed with one of these reporter plasmids and YEp351-YAP1 (50), which
overproduces Yap1p. The WT strain ABC154 (ade2) was also singly transformed
with the reporter plasmids to compare the transcriptional regulation of YCF1
and BPT1 in the presence of CdCl2 or a limited amount of adenine. Transfor-
mants were grown to log phase in selective medium, harvested, washed, resus-
pended in Z buffer, and assayed for -galactosidase activity (38). Measurements
were carried out in triplicate, and activity was expressed as -galactosidase units
per OD600 (optical density at 600 nm) unit of cells.
Quantitation of the red pigment that accumulates in an ade2 strain. To
quantitate the extent of pigment formation during growth of ade2 strains on
adenine-limiting medium, cells were grown to an OD600 ranging between 2.9 and
3.2 in YPD medium containing 0.5% yeast extract. An equal number of cells
from each strain (as determined by OD600) was harvested and washed with sterile
water. Cells were lysed in 5% sulfosalicylic acid by using glass beads, and cell
debris was removed by centrifugation at 15 K for 5 min. The amount of the
pigment was estimated by recording the absorbance at 530 nm (	max). Control
extracts were prepared in a similar manner by using strain ABC591 (gsh1) (41)
grown in the presence of excess adenine (5).
Growth inhibition by cadmium. To examine growth in liquid medium, cells
grown to saturation in YPD medium were subcultured at a starting OD600 of

0.1 into YPD medium containing different concentrations of CdCl2 and the
extent of growth after 30 h was determined by measuring the OD600. The growth
rate of each culture was also determined by taking OD600 readings at multiple
intervals throughout the entire 30-h period. In all cases, an alteration in the
extent of growth after 30 h is reflected as a corresponding alteration in the rate
of growth (data not shown).
To examine growth on plates, cells were grown overnight to saturation in
minimal medium, then subcultured at a 1:500 dilution into the same medium,
and grown overnight at 30°C to an OD600 of approximately 1.0. This overnight
culture was diluted to an OD600 of 0.1, which in turn was diluted in 10-fold
increments. Five microliters of each 10-fold dilution was spotted onto SC-Ura plates
containing different concentrations of CdSO4 and incubated for 3 days at 30°C.
Transport substrates. Radiolabeled 2,4-dinitrophenyl-glutathione ([3H]DNP-
GS) (418.7 mCi/mmol) was synthesized and purified as described previously (24).
Radiolabeled GSH ([3H]GSH) (44 Ci/mmol) and -estradiol 17-(-D-glucuro-
nide) ([3H]E217G) (55 mCi/mmol) were purchased from DuPont, NEN.
Transport assays. For in vitro transport measurements, vacuoles were isolated by
the Ficoll floatation technique from cells grown in YPD medium and were vesicu-
lated as described previously (23). The uptake of [3H]DNP-GS, [3H]E217G, or
[3H]GSH by yeast vacuolar membrane vesicles was measured at 25°C in 200-l
volumes containing 3 mM ATP, 3 mM MgSO4, 5 M gramicidin-D, 10 mM creatine
phosphate, 16 U of creatine phosphate kinase/ml, 50 mM KCl, 1 mg of bovine serum
albumin/ml, 400 mM sorbitol, 25 mM Tris-morpholineethanesulfonic acid (MES)
buffer (pH 8.0), and the indicated concentrations of radiolabeled transport substrate.
In the case of [3H]GSH, oxidation and the formation of oxidized GSH, [3H]GSSG,
was minimized by degassing all solutions before the dissolution of GSH and by
purging the freshly prepared GSH stock solutions and uptake media with nitrogen
gas immediately before use. In all cases, uptake was initiated by the addition of
membrane vesicles and was terminated by addition of 1 ml of ice-cold wash medium
(400 mM sorbitol in 3 mM Tris-MES buffer [pH 8.0]) and vacuum filtration of the
suspension through prewetted Millipore Durapore (GVWP) filters (pore size, 0.22
m). Filters were rinsed twice with wash medium, and the radioactivity retained was
determined by liquid scintillation counting. Nonenergized (MgATP-independent)
uptake was estimated by the same procedure, except that ATP was omitted from the
uptake medium.
Computations. Lines of best fit and kinetic parameters were estimated by
nonlinear least-squares analysis (29) using the Ultrafit nonlinear least-squares
curve-fitting package from BioSoft (Ferguson, Mo.).
RESULTS
Bpt1p, a homologue of yeast Ycf1p and mammalian MRP1,
localizes to the yeast vacuolar membrane. The GS conjugate
transport activities of Ycf1p in vivo and in vitro are well es-
TABLE 2. Plasmids used in this study
Plasmid Relevant genotypea Reference or source
pAB851 2m URA3 PBPT1-lacZ This study
pAB852 2m URA3 PYCF1-lacZ This study
pJAW53 YIp 5-1,018 nt-YCF1-hisG-URA3-hisG-3-1,356 nt-YCF1 50
pSM217 2m URA3 6
pSM1490 2m URA3 BPT1-GFP This study
pSM1753 2m URA3 YCF1-GFP This study
pSM1817 YIp URA3 YCF1-GFP This study
pSM1849 YIp URA3 BPT1-GFP This study
YEp351-YAP1 2m LEU2 YAP1 50
a YIp denotes a yeast integrating plasmid; nt, nucleotides.
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tablished (23, 25). In this study we analyzed Bpt1p, the closest
yeast homologue of Ycf1p. Bpt1p shares strong overall homol-
ogy with Ycf1p (42% identity and 59% similarity) as well as
with human MRP1 (38% identity and 57% similarity) (9). It
possesses a domain organization typical of most members of
the MRP subclass of ABC transporters, consisting of two mem-
brane-spanning domains (MSDs), each with six spans, and two
nucleotide binding domains (NBDs). Notably, Bpt1p and
Ycf1p also contain the N-terminal extension that is the hall-
mark of a subset of the MRP subfamily members and consists
of an additional membrane-spanning domain (MSD0) with five
spans, followed by a linker (L0) region (3).
Ycf1p localizes to the vacuolar membrane, as shown by
immunofluorescence and subcellular fractionation (23, 49). To
localize Bpt1p, we generated a Bpt1p-GFP fusion construct, as
well as its Ycf1p-GFP counterpart. The latter is fully func-
tional, as measured by its ability to confer cadmium resistance
on a ycf1 strain (data not shown). Fluorescence and Nomar-
ski microscopy were carried out for Bpt1p-GFP and Ycf1p-
GFP expressed from either the chromosome or a multicopy
plasmid. Bpt1p-GFP (Fig. 1A), like Ycf1p-GFP (Fig. 1B), ex-
hibits a clear-cut vacuolar membrane localization, as can be
seen by the correspondence of the vacuole indentation ob-
served by differential interference contrast (DIC) and GFP
fluorescence patterns. The brighter areas of fluorescence ap-
pear to correspond to regions where the multiple vacuolar
lobes intersect. The grainy fluorescence pattern in cells ex-
pressing single-copy versus multicopy Bpt1p-GFP and Ycf1p-
GFP is due to the long exposure required to enhance the dim
signal for the former. Based on the results above, Bpt1p, like
Ycf1p, would therefore be expected to be an ABC transporter
that delivers its cargo into the vacuole lumen.
Bpt1p contributes to the transport of the GS-conjugated
compound responsible for the red pigmentation of an ade2
strain in vivo. Since Bpt1p and Ycf1p reside in the same
membrane and share significant sequence identity, we were
interested to determine if they have overlapping transport
functions. As a starting point for these analyses, we generated
a bpt1 null mutant by homologous gene replacement using the
KanMX2 cassette to disrupt the BPT1 ORF in both MATa and
MAT haploid strains. Growth of the bpt1 null mutant is in-
distinguishable from that of the isogenic WT strain (data not
shown), indicating that BPT1 is not an essential gene under
normal growth conditions. Likewise, the growth of a double
null mutant (ycf1 bpt1) generated by a cross between the
single mutants is similar to that of the WT, although occasion-
ally a slight growth impairment could be observed with this
strain (for example, see Table 3, growth in 0 M CdCl2).
YCF1 has been shown to play an important role in the red
pigmentation of adenine biosynthetic mutants in S. cerevisiae
(5). Specifically, strains carrying ade1 or ade2 mutations accu-
mulate an intense red pigment in their vacuoles when they are
grown under conditions of adenine limitation. The formation
of this pigment involves a series of steps, including conjugation
of GSH to the adenine biosynthetic intermediate phosphori-
bosylaminoimidazole (AIR), transport of AIR-GS conjugates
into the vacuole in a Ycf1p-dependent manner, and further
metabolism of the pigment precursor after its vacuolar seques-
tration. In a ycf1 null mutant, pigmentation of an ade2 mutant
is diminished but not completely eliminated (5). Presumably,
residual pigmentation occurs because another cellular trans-
porter(s) can mediate the transport of AIR-GS conjugates.
To examine whether the residual pigmentation of the ade2
ycf1 strain involves Bpt1p, we quantitated the extent of pig-
ment formation in strains that had single and double disrup-
tions of BPT1 and YCF1. Quantitation was performed as de-
scribed in Materials and Methods, and data are averages of
four experiments  standard deviations. Pigment accumula-
tion, expressed as a percentage of that in the WT strain
ABC154, was 96%  8.4% for strain ABC791 (bpt1), 31% 
4.3% for strain ABC470 (ycf1), and 15%  6.8% for strain
ABC794 (bpt1 ycf1). Thus, as expected, pigment accumula-
tion was substantially decreased in the ycf1mutant (to 31% of
the WT level). Notably, the deletion of bpt1 in a ycf1 strain
background resulted in a further decrease in pigmentation (to
15% of the WT level in the ycf1 bpt1 double mutant), clearly
implicating Bpt1p in vacuolar pigment sequestration. How-
ever, the accumulation of pigment in the bpt1 null mutant was
not significantly different from that in the WT strain (96 versus
100%, respectively), presumably because the contribution of
Ycf1p overwhelmed that of Bpt1p. Thus, while Bpt1p is not a
major player in ade2 pigmentation when Ycf1p is present, it
does indeed appear to contribute to this process, as evidenced
by the finding that when the Ycf1p transporter is absent, a role
for Bpt1p is clearly revealed. From a genetic standpoint, the
FIG. 1. Bpt1p, like Ycf1p, localizes to the vacuolar membrane. The
GFP fluorescence pattern of cells expressing Bpt1p-GFP (A) or Ycf1p-
GFP (B) from the chromosome (panels 1 and 3) or from a multicopy
plasmid (panels 5 and 7) is shown. In the corresponding Nomarski
(DIC) images of these cells (A and B, panels 2, 4, 6, and 8), the vacuole
appears as an indentation. Strains used are SM4787 (A, panels 1 to 4),
SM3794/pSM1490 (A, panels 5 to 8), SM4643 (B, panels 1 to 4), and
SM3851/pSM1753 (B, panels 5 to 8).
394 SHARMA ET AL. EUKARYOT. CELL
ycf1 and bpt1 mutants exhibit “synthetic enhancement” of
the ade2 phenotype (15); the phenotype of the double mutant
is markedly more severe than that of either of the single mu-
tants.
The results of plate tests of the capacity of the BPT1 gene
expressed from a multicopy plasmid to restore ade2 pigmen-
tation in the ycf1 bpt1 double mutant are consistent with
these conclusions. Whereas the ycf1 bpt1 strain containing
an empty vector formed white to pale-pink colonies (Fig. 2A),
the ycf1 bpt1 strain harboring a BPT1 plasmid formed dark-
pink colonies (Fig. 2C), with a pigmentation intensity compa-
rable to that of the double-mutant strain harboring a YCF1
plasmid (Fig. 2B). Importantly, although this result is not
quantitative, it suggests that Bpt1p on its own, like Ycf1p, has
the capacity to function as a transporter for the GS-conjugated
ade2 pigment precursor.
Bpt1p contributes to cadmium detoxification, as evidenced
by synthetic enhancement of cadmium sensitivity in a ycf1
bpt1 double mutant. Ycfp1p contributes to cadmium detoxi-
fication in yeast by mediating the transport of Cd·GS com-
plexes into the vacuole (25). Compared to an isogenic WT
(YCF1) strain, a ycf1 mutant is hypersensitive to cadmium
salts (44). To determine whether Bpt1p also plays a role in
cadmium detoxification, we compared the growth of a WT
strain with that of strains that had single and double disrup-
tions of BPT1 and YCF1, both in liquid media and on plates
containing different concentrations of cadmium.
For liquid growth experiments, saturated overnight cultures
of each strain were subcultured into YPD medium containing
0, 50, or 100 M CdCl2 and were propagated for 30 h. The
extent of growth was determined by measuring the OD600 after
30 h (Table 3). All of the strains, including the WT, are subject
to growth retardation by 50 or 100 M CdCl2. As reported
previously, growth of the ycf1 strain was markedly retarded,
here attaining only 55 and 36% of the OD600 of the WT at 50
and 100 M CdCl2, respectively, confirming that Ycf1p is im-
portant for cadmium resistance. In contrast, growth of the
bpt1 strain was unaffected; this mutant strain attained 100%
of the OD600 of the WT at 50 and 100 M CdCl2, indicating
that Bpt1p is dispensable for cadmium detoxification when
Ycf1p is functional. However, a discernible contribution of
Bpt1p to cadmium detoxification was revealed in the double
(ycf1 bpt1) mutant, whose growth was significantly dimin-
ished in CdCl2 relative to that of the ycf1 single mutant (36%
versus 55% in 50 M CdCl2 and 21% versus 36% in 100 M
CdCl2). Augmentation of the ycf1 cadmium-sensitive pheno-
type through the abolition of Bpt1p function is consistent with
a synthetic enhancement, similar to that observed for the
Ade2 phenotype. Bpt1p can contribute to cadmium detoxifi-
cation in yeast, presumably by mediating the transport of
Cd · GS complexes into the vacuole, albeit at modest levels
compared to that of Ycf1p.
The results of plate tests yielded the same basic conclusion,
regardless of the background strain in which the single and
double mutants were generated. Results with strains derived
from YPH499 (42) (here designated ABC154) and EG123 (43)
FIG. 2. The ade2 pigmentation-defective phenotype of a double-
mutant strain (ycf1 bpt1) is complemented by a multicopy BPT1
plasmid. Strains were streaked onto an SC-Ura plate containing lim-
iting adenine (7.5 mg/liter) and were incubated for 3 days at 30°C. The
ycf1 bpt1 double-mutant strain containing an empty vector
(A) shows diminished pigmentation and is light pink. Expression of
YCF1-GFP (B) or BPT1-GFP (C) from a multicopy plasmid, pSM1753
or pSM1490, respectively, complements the pigmentation defect of the
ycf1 bpt1 double mutant, resulting in formation of dark-pink colo-
nies.
FIG. 3. Bpt1p contributes to cadmium detoxification. Strains de-
rived from ABC154 (A) and SM1058 (B) were tested for their capacity
to tolerate CdSO4. An aliquot of cells at 0.1 OD, and serial 10-fold
dilutions thereof, were spotted onto plates containing 0, 10, or 30 M
CdSO4 and incubated at 30°C for 3 days. The strains tested all harbor
the insertless plasmid pSM217 to permit growth on SC-Ura drop-out
media; they are (A) ABC154 (wild-type), ABC791 (bpt1), ABC470
(ycf1), and ABC794 (ycf1 bpt1); and (B) SM1058 (wild-type),
SM3794 (bpt1), SM3851 (ycf1), and SM3858 (ycf1 bpt1).
TABLE 3. Effects of cadmium on growth of WT and mutant strains
Straina
OD600b (% of WT) at:
0 M CdCl2 50 M CdCl2 100 M CdCl2
WT 8.4 (100) 1.1 (100) 1.1 (100)
bpt1 8.3 (99) 1.1 (100) 1.1 (100)
ycf1 7.9 (94) 0.6 (55) 0.4 (36)
ycf1 bpt1 7.6 (90) 0.4 (36) 0.2 (21)
a Strains used were ABC154 (WT), ABC791 (bpt1), ABC470 (ycf1), and
ABC794 (ycf1bpt1).
b Measured after 30 h of growth at 30°C. The OD600s of the starting cultures
were 0.14 for the WT and bpt1 strains and 0.13 for the ycf1 and ycf1 bpt1
strains.
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(here designated SM1058) are shown in Fig. 3A and B, respec-
tively. A culture of each strain was diluted to an OD600 of 0.1,
and serial dilutions were spotted onto plates without (0 M)
and with (10 and 30 M) cadmium. In the absence of cad-
mium, the growth of all strains is essentially equivalent (Fig. 3,
0 M CdSO4). On a plate containing the small amount of
cadmium (10 M CdSO4), growth of the bpt1 single mutant
in the ABC154 strain background is equivalent to that of the
WT strain. However, a role for Bpt1p is clearly revealed in the
double mutant ycf1 bpt1 at this cadmium concentration
(Fig. 3A; compare the modest growth of the ycf1 strain to the
lack of growth of the ycf1 bpt1 double-mutant strain at 10
M CdSO4). Although the phenotype of the SM1058-derived
strains on 10 M cadmium is not as severe as that of the
ABC154-derived strains (compare the growth of the ycf1
strain for each), a role for Bpt1p is also revealed by the double
mutant ycf1 bpt1 in this strain background on 10 M CdSO4
(Fig. 3B). On plates containing the higher concentration (30
M CdSO4), cadmium toxicity is of sufficient severity that
neither the ycf1 single mutant nor the ycf1 bpt1 double
mutant grows.
Bpt1p plays a role in the in vitro transport of GS conjugates,
glucuronides, and GSH into vacuole-derived vesicles. The in
vivo tests described above indicate that Bpt1p function par-
tially overlaps that of Ycf1p. To compare Bpt1p- and Ycf1p-
dependent transport biochemically, we isolated yeast vacuolar
membranes from wild-type, single-mutant, and double-mutant
strains and examined their capacities to mediate the MgATP-
energized transport of three canonical MRP substrates: the
GSH conjugate DNP-GS, the glucuronate conjugate E217G,
and reduced GSH. For all of these substrates, it was found that
the transport capabilities of Bpt1p overlapped with those of
Ycf1p to varying degrees; for two of the three substrates, Bpt1p
appeared to require Ycf1p for maximal activity.
Vesicular DNP-GS uptake was the first transport function to
be assayed, because this model GS conjugate is firmly estab-
lished as a substrate for Ycf1p. When assayed for time depen-
dence at a concentration of 10 M, DNP-GS uptake by WT
vesicles was 18.8 nmol of substrate in 5 min (Fig. 4A, inset).
Uptake by vesicles from a bpt1 single mutant was 13.5 nmol
of substrate in 5 min, representing a 28% decrease from the
transport capacity of the WT and indicating a modest but
observable contribution of Bpt1p to MgATP-dependent trans-
port of this conjugate. By contrast, the amount of DNP-GS
uptake by vesicles from a ycf1 single mutant and from a ycf1
bpt1 double mutant was 0.2 nmol of substrate in 5 min,
FIG. 4. MgATP-dependent uptake of [3H]DNP-GS, [3H]E217G,
and [3H]GSH by vacuolar membrane vesicles from WT and mutant
strains. For the large graphs in panels A, B, and C, MgATP-dependent
uptake of the indicated transport substrates was measured for 10 min,
at the concentrations of substrate indicated, in the presence or absence
of 3 mM ATP. The level of uptake at each substrate concentration was
calculated by subtracting the amount of radioactivity detected in the
absence of ATP from that detected when ATP was present. The data
were fitted to the Michaelis-Menten equation by nonlinear least-
squares analysis. The values obtained for each substrate and each
strain are as follows. (A) For the WT, Km(DNP-GS)  5.8  2.3 M and
Vmax(DNP-GS)  30.7  2.3 nmol/mg/10 min; for the bpt1 strain,
Km(DNP-GS) 6.3 3.8 M and Vmax(DNP-GS) 25.3 3.0 nmol/mg/10
min; for the ycf1 strain, Km(DNP-GS)  268.4  157 M and
Vmax(DNP-GS)  20.3  7.8 nmol/mg/10 min. (B) For the WT,
Km(E217G)  386.0  33.0 M and Vmax(E217G)  35.3  13.5 nmol/
mg/10 min; for the bpt1 strain, Km(E217G)  580.0  38.0 M and
Vmax(E217G)  23.2  8.0 nmol/mg/10 min. (C) For the WT, Km(GSH)
 3.8  0.4 mM and Vmax(GSH)  149.4  76.3 nmol/mg/10 min; for
the bpt1 strain, Km(GSH) 3.8 0.4 mM and Vmax(GSH) 87.5 43.3
nmol/mg/10 min. Kinetic parameters were not calculated for DNP-GS
uptake by the ycf1 bpt1 strain or for E217G and GSH uptake by
the ycf1 and ycf1 bpt1 mutants, because the data did not approx-
imate the Michaelis-Menten equation. Individual data points are
means  standard errors (n  3 to 6). The insets in panels A and B
show the time courses for DNP-GS and E217G uptake, respectively.
The strains used for the preparation of vacuolar vesicles are ABC154
(wild type), ABC470 (ycf1), ABC791 (bpt1), and ABC794 (ycf1
bpt1).
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representing a 95% decrease in transport capacity compared
to that of the WT.
These effects were similarly evident in the concentration
dependence of DNP-GS uptake (Fig. 4A). In a WT strain, the
bulk of the transport measured is attributable to Ycf1p, since
vesicles from a ycf1 strain are markedly decreased in their
transport efficacy compared to vesicles from a WT strain. The
Km for the WT versus ycf1 vesicles is 5.8  2.3 versus 268.4 
157.0 M; the corresponding Vmax values are 30.7  2.3 versus
20.3  7.8 nmol/mg/10 min, respectively (Fig. 4A). In contrast
to YCF1, the effects of disrupting the BPT1 gene were modest:
Km was negligibly affected relative to that of the WT (6.3  3.8
versus 5.8  2.3 M) and Vmax was only slightly attenuated
(25.3  3.0 versus 30.7  2.3 nmol/mg/10 min) (Fig. 4A). As
expected if Ycf1p mediates the bulk of DNP-GS transport, the
difference between the concentration-dependent uptake by
ycf1 single-mutant membranes and that by ycf1 bpt1 dou-
ble-mutant membranes was small (Fig. 4A).
By comparison with that of DNP-GS, transport of the other
substrates, the glucuronate conjugate E217G (Fig. 4B) and
reduced GSH (Fig. 4C), followed a different pattern. In both
cases, the relative contribution made by Bpt1p was greater,
implying that that this transporter has a preference for E217G
and GSH over DNP-GS. Vesicles from the bpt1 strain show
a 59% decrease in the capacity for uptake of 100 M E217G
(1.8 nmol of substrate in 5 min versus a WT value of 4.4 nmol
of substrate in 5 min) (Fig. 4B, inset). However, unexpectedly,
the contributions of Bpt1p and Ycf1p are not additive, as a
decrease in the amount of E217G uptake in the ycf1 single
mutant was 95%, not 41%. This low level of uptake was
similar to that of the ycf1 bpt1 double mutant (Fig. 4B).
A pattern comparable to that seen for E217G was also
observed for GSH. Disruption of the BPT1 gene diminished
the total capacity of the membranes for transport by more than
40%, whereas uptake of GSH was negligible throughout the
concentration range examined not only in the membrane ves-
icles from ycf1 bpt1 double-mutant cells but also in those
from ycf1 single-mutant cells (Fig. 4C).
BPT1 and YCF1 are differentially regulated transcription-
ally. Yap1p is a transcription factor that modulates the expres-
sion of a large number of yeast genes implicated in the re-
sponse to oxidative stress, for instance, stress resultant from
exposure to cadmium (31, 50). Since YCF1 is under the regu-
latory control of Yap1p, it was of interest to determine whether
BPT1 expression shares this characteristic. To compare the
influence of Yap1p on the expression patterns of YCF1 and
BPT1, we generated constructs in which the 5 upstream re-
gions of YCF1 and BPT1 were fused to the coding region of
lacZ. These reporter plasmids were transformed into WT,
yap1-defective, or YAP1-overexpressing strains that were sub-
sequently assayed for -galactosidase activity (Table 4).
Two features are evident from these expression studies.
First, the basal levels of YCF1 and BPT1 expression in a WT
strain are essentially the same (Table 4, rows 1 and 6), sug-
gesting that in the absence of inducer these transporters are
present at similar levels. Second, while the expression of YCF1
is strongly modulated by Yap1p, BPT1 expression is only mar-
ginally affected if at all. Mutational loss of Yap1p activity
results in an approximately 3-fold decrease in YCF1 expres-
sion. Conversely, Yap1p overexpression leads to an approxi-
mately 10-fold increase in YCF1 expression (Table 4, compare
rows 2 and 3 to row 1). This is in complete agreement with the
results of previous studies (50). In strict contrast, BPT1 expres-
sion was not affected by a lack of Yap1p and was only modestly
increased (
1.5-fold) by an excess of Yap1p.
Expression of the fusion constructs was also examined under
conditions of adenine deficiency and excess in order to assess
the effects of endogenous AIR-GS conjugates on YCF1 and
BPT1 expression. Limiting levels of adenine (0 g/ml) elicited
an approximately 5-fold increase in PYCF1 -lacZ expression
over that in cells subjected to excess adenine (60 g/ml), but an
increase of only 2.5-fold in PBPT1 -lacZ expression (Table 4,
compare rows 5 and 4). Analogous experiments employing
cadmium at 0 and 50 M as an inducer increased the expres-
sion of PYCF1 -lacZ and PBPT1 -lacZ by approximately 2.5- and
1.5-fold, respectively (Table 4, compare rows 6 and 7). The
strong induction of YCF1 observed under conditions of high
cadmium and limiting adenine may be partly or wholly medi-
ated through Yap1p. The modest transcriptional effects seen
for Bpt1p may also be mediated by Yap1p, or instead by
another, as yet undetermined transcription factor.
DISCUSSION
Bpt1p and Ycf1p are localized to the vacuolar membrane
and show overlapping transport properties in vivo. In this
study we compared the localization, expression, and substrate
transport properties of Bpt1p and its close homologue Ycf1p in
order to gain more insight into the MRP subfamily of ABC
transporters in yeast. The sequence and structural similarities
between Bpt1p and Ycf1p suggest that they might have similar
functions in vivo. To initiate studies of Bpt1p, we compared the
localization of C-terminally GFP-tagged Ycf1p and Bpt1p in
vivo. Fluorescence microscopy revealed that the localization of
Bpt1p-GFP is indeed vacuolar, like that of Ycf1p-GFP (Fig. 1).
These findings corroborate and extend the results of previous
in vitro experiments showing that vacuole-enriched membrane
preparations, which are at best only partially pure, mediate
Bpt1p-dependent transport activity (34, 37).
The vacuolar localization of Bpt1p is consistent with the
notion that it, like Ycf1p, contributes to the vacuolar seques-
tration of otherwise toxic compounds. Several possibilities can
be envisioned for how these transporters might function in the
TABLE 4. Comparison of the transcriptional regulation of YCF1
and BPT1
Trial no. Strain
a or substrate
concentration
-Galactosidase activityb of
strain bearing the indicated
fusion construct
PYCF1-lacZ PBPT1-lacZ
1 SEY6210 (WT) 2.53  0.12 2.37  0.12
2 SM13 (yap1) 0.85  0.07 2.17  0.08
3 SM13 (yap1 YEp351-
YAP1)
22.93  0.85 3.26  0.07
4 60 mg of adenine/liter 3.14  0.15 2.22  0.11
5 0 mg of adenine/liter 15.76  0.7 5.40  0.36
6 0 M CdCl2 2.72  0.45 2.34  0.34
7 50 M CdCl2 6.72  0.84 3.70  0.47
a Strain ABC154 (ade2) was used for each trial unless otherwise specified.
b Measured as described in Materials and Methods and expressed as -galac-
tosidase units per OD600 unit of cells.
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same intracellular environment. For example, Bpt1p and
Ycf1p could have identical substrate transport and regulatory
properties, and so function redundantly. Alternatively, these
transporters could have a distinct pattern of substrate selectiv-
ity and regulation, and function complementarily. Finally, a
combination of both of these schemes could apply, such that
Bpt1p and Ycf1p might exhibit functional and regulatory over-
lap under some circumstances and unique properties under
others. As detailed below, the latter combined view seems to
best explain the properties of Bpt1p and Ycf1p both in vivo
and in vitro.
To directly compare the contributions of Bpt1p and Ycf1p in
vivo, we generated bpt1 and ycf1 (single) and ycf1 bpt1
(double) mutants. Neither YCF1 nor BPT1 is essential for
viability. We used these mutants to examine two well-charac-
terized phenotypes known to involve Ycf1p: ade2 pigmentation
and cadmium resistance. These substrates were considered to
be particularly appropriate because they share the property of
being conjugated to, or complexed with, GSH yet are either of
endogenous (the biosynthetic intermediate AIR) or exogenous
(cadmium) origin. We show here that Bpt1p, like Ycf1p, plays
a role in ade2 pigmentation and cadmium detoxification (Table
3; Fig. 2 and 3). While Ycf1p accounted for most of the trans-
port measured for both substrates, Bpt1p made a minor but
demonstrable contribution. Specifically, in the ycf1 single mu-
tant, ade2 pigmentation was strongly reduced (by 70%) com-
pared to that in the WT, and growth in the presence of Cd2
was strongly inhibited (by 64% at 100 M CdCl2) (Table 3).
Although the bpt1mutation alone did not result in a defect in
ade2 pigmentation or cadmium resistance, a function for Bpt1p
was clearly evident in the ycf1 bpt1 double mutant, whose
phenotype was significantly more severe than that of the ycf1
single mutant. Both ade2 pigment accumulation and growth in
100 M CdCl2 (Table 3) were reduced by a further 15% in the
ycf1 bpt1 double mutant versus the ycf1 single mutant.
The phenomenon observed here for Bpt1p, in which the
single bpt1 and ycf1 mutants show no phenotype, or only a
modest one, but the double mutant is severely impaired, can be
referred to as “synthetic enhancement” (15). Generally, genes
which exhibit synthetic enhancement are intimately connected
functionally, either as interacting components or, in the case of
deletion mutations, more likely as functionally redundant pro-
teins. With Bpt1p and Ycf1p, the latter mode of synthetic
enhancement is the more likely. Thus, Ycf1p alone (i.e., in a
bpt1 mutant) is sufficient for full transport of the substrates
tested in vivo here. In the absence of Ycf1p (i.e., in a ycf1
mutant), there is still residual function. This must be due to
Bpt1p, since in the ycf1 bpt1 double mutant, transport is
decreased even further. Independent corroboration of the abil-
ity of Bpt1p to function as a transporter is provided by the
finding that its overexpression in the ycf1 bpt1 double mu-
tant rescues the ade2 pigmentation defect (Fig. 2).
BPT1 and YCF1 are differentially regulated. The smaller
contribution of Bpt1p, compared to Ycf1p, to the transport of
in vivo substrates could be due solely to the distinct substrate
preferences of these transporters. Alternatively, or addition-
ally, the lower contribution of Bpt1p could reflect a lower
relative level of expression than that of Ycf1p. The possibility
of differentially regulated expression of YCF1 versus BPT1 is
supported by promoter fusion studies (Table 4). YCF1 expres-
sion is exquisitely sensitive to the dosage of Yap1p, a transcrip-
tion factor involved in responses to oxidative stress. PYCF1-lacZ
expression is decreased 3-fold in the absence of Yap1p and is
increased 10-fold when Yap1p is overexpressed. In contrast,
PBPT1-lacZ expression exhibits no, or at most very little, de-
pendence on Yap1p; it is insensitive to the absence of Yap1p
and only modestly elevated (
1.5-fold) by Yap1p overexpres-
sion. Since cadmium resistance involves regulatory effects ex-
erted through Yap1p, it is not surprising that PYCF1-lacZ ex-
pression is increased to a greater extent than that of PBPT1-lacZ
in 50 M Cd (
2.5- versus 1.5-fold, respectively [Table 4]). It
is established that the strong Cd2-induced increase in YCF1
expression is indeed dependent on Yap1p (50), but it is not
known if the modest increase in BPT1 expression elicited by
Cd2 is mediated by Yap1p or by another transcription factor.
By analogy with the results obtained with Cd2, we find that
PYCF1-lacZ expression is substantially induced (fivefold) under
conditions of adenine limitation, in which the ade2 pigment
precursor (AIR) is present, while BPT1 expression is only
modestly induced (twofold). Thus, the presence of the ade2
pigment precursor results in overrepresentation of Ycf1p rel-
ative to Bpt1p. It is instructive to note that it is the presence of
substrate and not the growth conditions per se that result in
YCF1 induction, since in a WT ADE2 strain exposed to con-
ditions of adenine limitation, this induction does not occur
(K. G. Sharma and A. K. Bachhawat, unpublished data).
Extrapolating from our gene expression data in Table 4, it is
likely that at the level of protein expression Ycf1p and Bpt1p
are roughly equivalent under normal conditions. However, the
relative amounts of Ycf1p may exceed those of Bpt1p when
cells are treated with Cd2. Therefore, Ycf1p should make
proportionately the greatest contribution to Cd2 resistance in
WT cells, masking the contribution of Bpt1p. Thus, differences
in BPT1 and YCF1 gene expression mediated through Yap1p
and potentially other transcription factors may be largely re-
sponsible for the distinct phenotypic contributions of Bpt1p
and Ycf1p in vivo. Clearly, the ability of these transporters to
be differentially regulated expands the range of environmental
or endogenous insults which yeast cells can tolerate.
Bpt1p and Ycf1p exhibit distinct substrate preferences in in
vitro transport assays. We were interested in comparing the
transport properties of Bpt1p and Ycf1p for canonical MRP sub-
strates in vitro. To do so, we isolated a vacuolar membrane-
enriched fraction from WT, single-mutant, and double-mutant
cells and determined the kinetics of transport of a model GS
conjugate (DNP-GS), a model glucuronate conjugate (E217G),
and unconjugated GSH. The activity we measured in the in vitro
transport assay (Fig. 4) reflects the basal levels of Bpt1p and
Ycf1p, since the cells used for preparation of the vacuole-en-
riched fraction were grown in the absence of inducer. From the
results of these in vitro measurements, it is clear that Bpt1p and
Ycf1p overlap in their transport capabilities but exhibit distinct
substrate preference profiles. On the one hand, Bpt1p appears to
favor glucuronate conjugates and free GSH over GS conjugates
(Fig. 4). On the other hand, vesicles from a ycf1 mutant are
severely (95%) impaired for the transport of all three sub-
strates, suggesting that Ycf1p plays a major and essential role in
the transport of all three substrates (see below).
Although for the substrates tested here, ycf1 vesicles were
less effective in transport than bpt1 vesicles, this pattern ap-
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pears not to be universal for all substrates. Two recent studies
examined the substrate transport properties for unconjugated
bile pigment (UCB) (37) and several MRI contrast reagents
(Gd-EOB·DTPA, Gd-BOPTA, Gd-B 20790, and Gd-B 21690)
(34), comparing vesicles from WT and mutant strains. Taken
together, the results from our study and those previous studies
show that Ycf1p is the major (50%) contributor to the trans-
port of UCB, Gd-BOPTA, DNP-GS, E217G, and GSH. In
contrast, Bpt1p and Ycf1p contribute approximately equally to
Gd-B 20790 transport, and Bpt1p is the major contributor to
Gd-EOB·DPTA transport. This pattern of overlapping but
nonidentical substrate preference for yeast MRPs is reminis-
cent of what has been documented for the mammalian MRP1
to MRP5 proteins (20, 22) and the vacuolar GS conjugate
pumps AtMRP1 and AtMRP2 from plants (26–28), suggesting
that this is a recurrent theme within the MRP subfamily in all
organisms.
A notable difference between the in vitro transport of some
substrates (i.e., E217G [this study]) and that of others (i.e.,
UCB) (37) is the lack of additivity of Bpt1p and Ycf1p activ-
ities. For example, since we observed a 59% diminution of
E217G transport in bpt1 vacuolar membrane vesicles, we
expected that the equivalent fraction from ycf1 cells would
show a reduction of 41%. However, unexpectedly, what we
saw instead was a diminution of 95% in the ycf1 single-
mutant strain and no further reduction of transport activity in
the ycf1 bpt1 double-mutant strain. Thus, Bpt1p appears to
contribute to the transport of E217G (Fig. 4B), and similarly
GSH (Fig. 4C), only in the presence of Ycf1p. How might this
surprising dependence be explained? One model to account
for these findings is that Bpt1p and Ycf1p may interact com-
binatorially to form a heterodimer. For the three substrates
tested here, such a Bpt1p/Ycf1p heterodimer would have op-
timal transport activity, while Bpt1p alone or as a homodimer
is inactive and Ycf1p alone or as a homodimer has intermedi-
ate activity. This model is appealing not only because it is
consistent with the present data but also in light of a recent
structural study of MRP1 which suggests that it exists predom-
inantly as a dimeric structure (39). An alternative model is that
another component which is lacking or down-regulated in both
the ycf1 and ycf1 bpt1 strains is necessary for maximal
Bpt1p activity.
MRP proteins in yeast. Comparison of the yeast MRP pro-
teins Bpt1p and Ycf1p highlights the point that despite their
sequence similarity, MRPs can exhibit biologically important
differences, including differential substrate specificity and reg-
ulatory properties. There are four additional genes that encode
MRPs in yeast: YBT1 (first published as BAT1), YOR1,
YHL035, and YKR103/YKR104 (12, 45). Sequence alignments
suggest that all of these contain a full or partial N-terminal
extension. Ybt1p is a vacuolar membrane protein that can
transport bile acid, but apparently not GS-conjugated com-
pounds (33), and Yor1p is a plasma membrane protein that
plays a role in oligomycin resistance (13, 19). The products of
the remaining two genes, YHL035 and YKR103/YKR104, re-
main uncharacterized. It is noteworthy that the latter actually
encodes two adjacent reading frames separated by a nonsense
codon, likely representing a sequencing error or a mutation in
the strain used to sequence the yeast genome. It is clear from
the present study that developing a complete picture of detox-
ification and related processes in yeast will require an under-
standing of the distinct localization patterns, expression pro-
files, and substrate transport properties of all of the yeast
MRPs.
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